Global Chronic Myeloid Leukemia Treatment Market By Therapy (Targeted Therapy, Immunotherapy, Chemotherapy, and Stem Cell Therapy), By Route of Administration (Oral, Parenteral, and Others), By Treatment Provider (Hospitals, Speciality Clinics, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: Dec 2024
- Report ID: 135771
- Number of Pages: 200
- Format:
-
keyboard_arrow_up
-
-
- Hoffmann-La Roche Ltd.
- Teva Pharmaceutical Industries Ltd. Company Profile
- Sanofi Company Profile
- Pfizer Inc Company Profile
- GSK plc
- Novartis AG Company Profile
- Bayer AG Company Profile
- Merck & Co., Inc.
- Abbott Laboratories
- AbbVie Inc. Company Profile
- Sun Pharmaceutical Industries Ltd.
- Lupin Ltd Company Profile
- Hikma Pharmaceuticals PLC
- settingsSettings
Our Clients
- 135771
- Dec 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
